VARIABILITY IN CHOLESTEROL CONTENT AND PHYSICAL-PROPERTIES OF LIPOPROTEINS CONTAINING APOLIPOPROTEIN B-100

被引:67
作者
ABATE, N
VEGA, GL
GRUNDY, SM
机构
[1] UNIV TEXAS, SW MED CTR, CTR HUMAN NUTR, DALLAS, TX 75235 USA
[2] UNIV TEXAS, SW MED CTR, DEPT CLIN NUTR, DALLAS, TX 75235 USA
[3] UNIV TEXAS, SW MED CTR, DEPT INTERNAL MED, DALLAS, TX 75235 USA
[4] UNIV TEXAS, SW MED CTR, DEPT BIOCHEM, DALLAS, TX 75235 USA
[5] VET ADM MED CTR, DALLAS, TX 75216 USA
关键词
CHOLESTEROL; APOLIPOPROTEIN B-100; LDL; NONHDL; LDL PATTERNS;
D O I
10.1016/0021-9150(93)90187-Y
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The primary objective of this study was to determine the variability in cholesterol carrying capacity of low density lipoproteins (LDLs) and other apolipoprotein B (ape B)-containing lipoproteins in normolipidemic men. One hundred and fifty-nine normolipidemic men, ages 21 to 73 years, were enrolled. In addition to determining plasma lipids and lipopropoteins, three primary measurements were made: ratios of cholesterol to apo B in LDL; the electrophoretic pattern of LDL, i.e. pattern A, AB, or B; and levels of cholesterol in all lipoproteins other than high density lipoproteins (nonHDL-cholesterol) along with total apo B. First, the data revealed that about 85%, of the variability of LDL-cholesterol levels can be accounted for by LDL-apo B levels, whereas the remaining 15% can be explained by differences in LDL-cholesterol/apo B ratios. Second, LDL electrophoretic pattern A was the predominant pattern in young adult men, but in older men the pattern shifted increasingly to AB and B. And third, there was a high correlation between nonHDL-cholesterol levels and total apo B levels, which suggests that nonHDL-cholesterol can be used as a relatively accurate surrogate for total apo B levels in normolipidemic individuals.
引用
收藏
页码:159 / 171
页数:13
相关论文
共 37 条
[11]   EFFECT OF HIGH-CARBOHYDRATE INTAKE ON HYPERGLYCEMIA, ISLET FUNCTION, AND PLASMA-LIPOPROTEINS IN NIDDM [J].
GARG, A ;
GRUNDY, SM ;
KOFFLER, M .
DIABETES CARE, 1992, 15 (11) :1572-1580
[12]   LIPOPROTEIN-MEDIATED CELLULAR MECHANISMS FOR ATHEROGENESIS IN HYPERTRIGLYCERIDEMIA [J].
GIANTURCO, SH ;
BRADLEY, WA .
SEMINARS IN THROMBOSIS AND HEMOSTASIS, 1988, 14 (02) :165-169
[13]   HYPERTRIGLYCERIDEMIA - CAUSES AND RELATION TO CORONARY HEART-DISEASE [J].
GRUNDY, SM ;
VEGA, GL .
SEMINARS IN THROMBOSIS AND HEMOSTASIS, 1988, 14 (02) :149-164
[14]   KINETIC MECHANISMS DETERMINING VARIABILITY IN LOW-DENSITY LIPOPROTEIN LEVELS AND RISE WITH AGE [J].
GRUNDY, SM ;
VEGA, GL ;
BILHEIMER, DW .
ARTERIOSCLEROSIS, 1985, 5 (06) :623-630
[15]   2 DIFFERENT VIEWS OF THE RELATIONSHIP OF HYPERTRIGLYCERIDEMIA TO CORONARY HEART-DISEASE - IMPLICATIONS FOR TREATMENT [J].
GRUNDY, SM ;
VEGA, GL .
ARCHIVES OF INTERNAL MEDICINE, 1992, 152 (01) :28-34
[16]   MULTIFACTORIAL ETIOLOGY OF HYPERCHOLESTEROLEMIA - IMPLICATIONS FOR PREVENTION OF CORONARY HEART-DISEASE [J].
GRUNDY, SM .
ARTERIOSCLEROSIS AND THROMBOSIS, 1991, 11 (06) :1619-1635
[17]   CHOLESTEROL ACCUMULATION IN J774 MACROPHAGES INDUCED BY TRIGLYCERIDE-RICH LIPOPROTEINS - COMPARISON OF VERY LOW-DENSITY-LIPOPROTEIN FROM SUBJECTS WITH TYPE-III, TYPE-IV, AND TYPE-V HYPERLIPOPROTEINEMIAS [J].
HUFF, MW ;
EVANS, AJ ;
SAWYEZ, CG ;
WOLFE, BM ;
NESTEL, PJ .
ARTERIOSCLEROSIS AND THROMBOSIS, 1991, 11 (02) :221-233
[18]   SERUM CHOLESTEROL, LIPOPROTEINS, AND RISK OF CORONARY HEART DISEASE - FRAMINGHAM STUDY [J].
KANNEL, WB ;
CASTELLI, WP ;
GORDON, T ;
MCNAMARA, PM .
ANNALS OF INTERNAL MEDICINE, 1971, 74 (01) :1-+
[19]   RECEPTOR-MEDIATED CATABOLISM OF LOW-DENSITY LIPOPROTEIN IN MAN - QUANTITATION USING GLUCOSYLATED LOW-DENSITY LIPOPROTEIN [J].
KESANIEMI, YA ;
WITZTUM, JL ;
STEINBRECHER, UP .
JOURNAL OF CLINICAL INVESTIGATION, 1983, 71 (04) :950-959
[20]  
KRAUSS RM, 1982, J LIPID RES, V23, P97